COMMUNIQUÉ DE PRESSE publié le 23/05/2024 à 14:00, il y a 3 mois 27 jours Bausch Health, Canada Inc. Announces Additional Public Drug Plan Listings for PrUCERIS(R) (Budesonide) Aerosol Foam To Treat Mild to Moderate Distal Ulcerative Colitis in Adults Bausch Health Canada expands UCERIS availability in Canadian public drug plans for ulcerative colitis treatment. UCERIS foam offers better tolerability and application compared to enema Ulcerative Colitis UCERIS Public Drug Plans Bausch Health Canada Gastrointestinal Franchise
BRÈVE publiée le 17/05/2024 à 14:05, il y a 4 mois 2 jours Salix Pharmaceuticals dévoilera les résultats de phase 2 de l'Amiselimod lors de la Semaine des maladies digestives 2024 Rectocolite Hémorragique Essai Clinique Salix Pharmaceutique Amiselimod Semaine Des Maladies Digestives
BRÈVE publiée le 17/05/2024 à 14:05, il y a 4 mois 2 jours Salix Pharmaceuticals to Unveil Amiselimod Phase 2 Results at Digestive Disease Week 2024 Salix Pharmaceuticals Ulcerative Colitis Clinical Trial Digestive Disease Week Amiselimod
COMMUNIQUÉ DE PRESSE publié le 17/05/2024 à 14:00, il y a 4 mois 2 jours Salix to Present Late-Breaking Data from Phase 2 Trial of Amiselimod in Active Ulcerative Colitis at Digestive Disease Week 2024 Bausch Health & Salix Pharmaceuticals to present Phase 2 trial data on Amiselimod for ulcerative colitis treatment at DDW 2024. Positive results announced in 2023 Salix Pharmaceuticals Ulcerative Colitis Bausch Health DDW 2024 Amiselimod
BRÈVE publiée le 15/05/2024 à 14:05, il y a 4 mois 4 jours Bausch Health Announces 2024 Annual Meeting of Shareholder Results Corporate Governance Bausch Health Shareholder Meeting Executive Compensation Omnibus Incentive Plan
BRÈVE publiée le 15/05/2024 à 14:05, il y a 4 mois 4 jours Bausch Health annonce les résultats de l’assemblée annuelle des actionnaires 2024 Assemblée Générale Gouvernance D'Entreprise Bausch Santé Rémunération Des Dirigeants Plan Incitatif Omnibus
COMMUNIQUÉ DE PRESSE publié le 15/05/2024 à 14:00, il y a 4 mois 4 jours Bausch Health Announces 2024 Annual Meeting of Shareholder Results Bausch Health Companies Inc. announces results of 2024 annual meeting of shareholders, including election of directors and approval of executive compensation Shareholders Bausch Health Companies Inc. Annual Meeting Directors Executive Compensation
BRÈVE publiée le 14/05/2024 à 22:26, il y a 4 mois 5 jours Bausch Health Announces Updates on Norwich XIFAXAN Litigation and New FDA Submission XIFAXAN Bausch Health Patent Litigation FDA Submission Norwich Pharmaceuticals
BRÈVE publiée le 14/05/2024 à 22:26, il y a 4 mois 5 jours Bausch Health annonce des mises à jour sur le litige Norwich XIFAXAN et une nouvelle soumission à la FDA XIFAXAN Bausch Santé Contentieux Des Brevets Norwich Pharmaceutique Soumission À La FDA
COMMUNIQUÉ DE PRESSE publié le 14/05/2024 à 22:21, il y a 4 mois 5 jours Bausch Health Announces Updates Related to Norwich XIFAXAN Matters Bausch Health and Salix Pharmaceuticals provide updates on litigation with Norwich Pharmaceuticals and potential generic version of XIFAXAN. Bausch Health to enforce intellectual property rights. Details on FDA approval process and patent infringement lawsuit Salix Pharmaceuticals XIFAXAN Bausch Health Norwich Pharmaceuticals Intellectual Property Rights
Publié le 19/09/2024 à 17:45, il y a 6 heures 24 minutes Gimv draagt helft van participatie in Infravest over aan WorxInvest (communicatie in toepassing van artikel 7:97 WVV)
Publié le 19/09/2024 à 17:45, il y a 6 heures 24 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 17:45, il y a 6 heures 24 minutes Gimv sells half of participation in Infravest to WorxInvest (communication pursuant to article 7:97 BCAC)
Publié le 19/09/2024 à 23:15, il y a 54 minutes Cypher Metaverse Inc. Announces Second Closing of Financing
Publié le 19/09/2024 à 23:00, il y a 1 heure 9 minutes WestJet Partners with FLYHT and NOAA to Improve Weather Forecasting in North America
Publié le 19/09/2024 à 20:15, il y a 3 heures 54 minutes Living Security Named a Leader in Human Risk Management, Closely Watched Tech Industry Report
Publié le 19/09/2024 à 21:09, il y a 2 heures 59 minutes EQS-Adhoc: Mercedes-Benz Group AG adjusts full-year guidance for the year 2024 based on current market outlook
Publié le 19/09/2024 à 18:44, il y a 5 heures 24 minutes Fuller, Smith & Turner PLC: Transaction in own shares
Publié le 19/09/2024 à 18:03, il y a 6 heures 6 minutes Funding Circle Plc: POS-Transaction in Own Shares
Publié le 19/09/2024 à 17:52, il y a 6 heures 16 minutes PILOT 28 : FIGEAC AÉRO remporte 3 nouveaux contrats sur l'A320 pour 65 millions d'euros
Publié le 19/09/2024 à 17:52, il y a 6 heures 16 minutes PILOT 28: FIGEAC AÉRO secures 3 new wins on the A320 airframe for 65 million euros